West Pharmaceutical: Q2 Earnings Snapshot

West Pharmaceutical Services Inc. reported Q2 profit of $154 million, or $2.15 per share, with adjusted earnings of $2.37 per share, exceeding analysts' expectations of $2.08 per share. The company also surpassed revenue forecasts with $872.3 million and provided guidance for higher-than-expected earnings and revenue in the current and full-year periods.